- Home
- ZIP vs FTRE Comparison
ZIP vs FTRE Comparison
Compare ZIP & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIP
- FTRE
- Stock Information
- Founded
- ZIP 2010
- FTRE 1996
- Country
- ZIP United States
- FTRE United States
- Employees
- ZIP N/A
- FTRE N/A
- Industry
- ZIP Diversified Commercial Services
- FTRE Medical Specialities
- Sector
- ZIP Consumer Discretionary
- FTRE Health Care
- Exchange
- ZIP Nasdaq
- FTRE Nasdaq
- Market Cap
- ZIP 508.3M
- FTRE 469.0M
- IPO Year
- ZIP 2021
- FTRE N/A
- Fundamental
- Price
- ZIP $4.59
- FTRE $6.09
- Analyst Decision
- ZIP Hold
- FTRE Hold
- Analyst Count
- ZIP 5
- FTRE 11
- Target Price
- ZIP $7.80
- FTRE $18.00
- AVG Volume (30 Days)
- ZIP 944.6K
- FTRE 2.3M
- Earning Date
- ZIP 05-08-2025
- FTRE 05-12-2025
- Dividend Yield
- ZIP N/A
- FTRE N/A
- EPS Growth
- ZIP N/A
- FTRE N/A
- EPS
- ZIP N/A
- FTRE N/A
- Revenue
- ZIP $474,001,000.00
- FTRE $2,696,400,000.00
- Revenue This Year
- ZIP N/A
- FTRE N/A
- Revenue Next Year
- ZIP $12.69
- FTRE $3.32
- P/E Ratio
- ZIP N/A
- FTRE N/A
- Revenue Growth
- ZIP N/A
- FTRE N/A
- 52 Week Low
- ZIP $4.74
- FTRE $4.77
- 52 Week High
- ZIP $11.25
- FTRE $37.24
- Technical
- Relative Strength Index (RSI)
- ZIP 32.07
- FTRE 43.72
- Support Level
- ZIP $5.11
- FTRE $5.40
- Resistance Level
- ZIP $5.82
- FTRE $6.10
- Average True Range (ATR)
- ZIP 0.31
- FTRE 0.43
- MACD
- ZIP -0.02
- FTRE 0.20
- Stochastic Oscillator
- ZIP 2.68
- FTRE 70.59
About ZIP ZipRecruiter Inc.
ZipRecruiter Inc is an online employment marketplace. It connects millions of job seekers with companies of all sizes. It is a two-sided marketplace for work that simplifies the job market for both job seekers and employers. Unlike traditional online job sites, ZipRecruiter works like a matchmaker curating job opportunities for job seekers, and candidates for employers.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.